Skip to content

Clinical implementation of advanced MRI techniques for localization and monitoring of sensorimotor and cognitive functions in patients with brain tumors

Clinical implementation of advanced MRI techniques for localization and monitoring of sensorimotor and cognitive functions in patients with brain tumors - Clinical implementation of advanced MRI techniques

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44896
Enrollment
330
Registered
2015-01-16
Start date
2015-07-07
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hersentumoren (meningioom en laaggradige gliomen) brain tumor glioma

Interventions

None listed

Sponsors

Sint Elisabeth Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: Adult patients diagnosed with a glioma or meningioma, age 18 - 75 Healthy subjects: age 18 - 75

Exclusion criteria

Exclusion criteria: Patients: metal objects in or around the body (braces, pacemaker, metal fragments) that are incompatible with MRI scan procedure Healthy subjects: metal objects in or around the body (braces, pacemaker, metal fragments) that are incompatible with MRI scan procedure

Design outcomes

Primary

MeasureTime frame
study 1.1: development of cognitive test paradigms suitable for fMRI, that provide behavioral measurements that correlate with neuropsychological performance study 1.2: application in healthy controls of cognitive fMRI protocols based on the best performing test paradigms from study 1.1 in order to test for robustness and reliability study 2.1: application in patient cohorts of cognitive best performing fMRI protocols developed in study 2.1 to test for correlation of brain activity measures that correlate significantly with neuropsychological performance.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)